Considerations on biologicals for patients with allergic disease in times of the COVID‐19 pandemic: An EAACI statement

The outbreak of the SARS‐CoV‐2‐induced coronavirus disease 2019 (COVID‐19) pandemic re‐shaped doctor‐patient interaction and challenged capacities of healthcare systems. It created many issues around the optimal and safest way to treat complex patients with severe allergic disease. A significant num...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Allergy
Asıl Yazarlar: Vultaggio, Alessandra, Agache, Ioana, Akdis, Cezmi A., Akdis, Mubeccel, Bavbek, Sevim, Bossios, Apostolos, Bousquet, Jean, Boyman, Onur, Chaker, Adam M., Chan, Susan, Chatzipetrou, Alexia, Feleszko, Wojciech, Firinu, Davide, Jutel, Marek, Kauppi, Paula, Klimek, Ludger, Kolios, Antonios, Kothari, Akash, Kowalski, Marek L., Matucci, Andrea, Palomares, Oscar, Pfaar, Oliver, Rogala, Barbara, Untersmayr, Eva, Eiwegger, Thomas
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: John Wiley and Sons Inc. 2020
Konular:
Eaaci Position Papers
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC7300800/
https://ncbi.nlm.nih.gov/pubmed/32500526
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/all.14407
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller